Randomised control trial of oxygen assist module in preterm infants on high-flow nasal cannula support
Conclusion
A-FiO2 was associated with statistically significant reduction in the percentage of time spent in extremes of saturation when compared with M-FiO2 in preterm infants receiving HFNC.
Trial registration number
NCT04687618.
Source: Archives of Disease in Childhood - Fetal and Neonatal Edition - Category: Perinatology & Neonatology Authors: Nair, V., Kannan Loganathan, P., Lal, M. K., Bachman, T. E., Fantl, R. Tags: Original research Source Type: research